Skip to main content
. 2022 Aug 4;9:966049. doi: 10.3389/fcvm.2022.966049

Table 1.

Classification of lipid-lowering drugs according to their ability to reduce cholesterol.

Lowering ability Treatments
Extreme Evolocumab 140 mg
Alirocumab 75 mg
Alirocumab 150 mg
Very high Potent statin + ezetimibe
Atorvastatin 40–80 mg + ezetimibe 10 mg
Rosuvastatin 10–40 mg + ezetimibe 10 mg
High High-potency statin
Atorvastatin 40–80 mg
Rosuvastatin 20–40 mg
Medium-potency statin + ezetimibe
Simvastatin 20-40 mg + ezetimibe 10 mg
Pravastatin 40 mg + ezetimibe 10 mg
Lovastatin 40 mg + ezetimibe 10 mg
Fluvastatin 80 mg + ezetimibe 10 mg
Pitavastatin 2–4 mg + ezetimibe 10 mg
Atorvastatin 10–20 mg + ezetimibe 10 mg
Rosuvastatin 5 mg + ezetimibe 10 mg
Moderate Medium-potency statin
Atorvastatin 10–20 mg
Rosuvastatin 5–10 mg
Simvastatin 20–40 mg
Pravastatin 40 mg
Lovastatin 40 mg
Pitavastatin 2–4 mg
Fluvastatin XL 80 mg
Low-potency statin + ezetimibe
Simvastatin 10 mg + ezetimibe 10 mg
Pravastatin 20 mg + ezetimibe 10 mg
Lovastatin 20 mg + ezetimibe 10 mg
Fluvastatin 40 mg + ezetimibe 10 mg
Pitavastatin 1 mg + ezetimibe 10 mg

Source: Escobar et al. (22).